Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 53 entries
Sorted by: Best Match Show Resources per page
Antidepressant/anxiolytic and anti-nociceptive effects of novel 2-substituted 1,4-benzodiazepine-2-ones.

Scientia pharmaceutica

Singh H, Sattayasai J, Lattmann P, Boonprakob Y, Lattmann E.
PMID: 21179341
Sci Pharm. 2010 Apr-Jun;78(2):155-69. doi: 10.3797/scipharm.1004-12. Epub 2010 May 17.

Oxazepam (4a) has been used as overall starting material in the synthesis of novel 2-substituted 1,4-benzodiazepines.By reacting Oxazepam 4a with commercially available hydrazines, hydrazides, semicarbazide, aminoguanidine and N,N-dimethylamino aniline in ethanol under acetic conditions, a series of diazenyl-1,4-benzodiazepines 5aâ5i...

Cite
Singh H, Sattayasai J, Lattmann P, et al. Antidepressant/anxiolytic and anti-nociceptive effects of novel 2-substituted 1,4-benzodiazepine-2-ones. Sci Pharm. 2010;78(2):155-69doi: 10.3797/scipharm.1004-12.
Singh, H., Sattayasai, J., Lattmann, P., Boonprakob, Y., & Lattmann, E. (2010). Antidepressant/anxiolytic and anti-nociceptive effects of novel 2-substituted 1,4-benzodiazepine-2-ones. Scientia pharmaceutica, 78(2), 155-69. https://doi.org/10.3797/scipharm.1004-12
Singh, Harjit, et al. "Antidepressant/anxiolytic and anti-nociceptive effects of novel 2-substituted 1,4-benzodiazepine-2-ones." Scientia pharmaceutica vol. 78,2 (2010): 155-69. doi: https://doi.org/10.3797/scipharm.1004-12
Singh H, Sattayasai J, Lattmann P, Boonprakob Y, Lattmann E. Antidepressant/anxiolytic and anti-nociceptive effects of novel 2-substituted 1,4-benzodiazepine-2-ones. Sci Pharm. 2010 Apr-Jun;78(2):155-69. doi: 10.3797/scipharm.1004-12. Epub 2010 May 17. PMID: 21179341; PMCID: PMC3002793.
Copy Download .nbib Format: NLM
Real-Time Nanoparticle-Cell Interactions in Physiological Media by Atomic Force Microscopy.

ACS sustainable chemistry & engineering

Pyrgiotakis G, Blattmann CO, Demokritou P.
PMID: 25068097
ACS Sustain Chem Eng. 2014 Jul 07;2(7):1681-1690. doi: 10.1021/sc500152g. Epub 2014 Jun 10.

Particle-cell interactions in physiological media are important in determining the fate and transport of nanoparticles and biological responses to them. In this work, these interactions are assessed in real time using a novel atomic force microscopy (AFM) based platform....

Cite
Pyrgiotakis G, Blattmann CO, Demokritou P. Real-Time Nanoparticle-Cell Interactions in Physiological Media by Atomic Force Microscopy. ACS Sustain Chem Eng. 2014;2(7):1681-1690doi: 10.1021/sc500152g.
Pyrgiotakis, G., Blattmann, C. O., & Demokritou, P. (2014). Real-Time Nanoparticle-Cell Interactions in Physiological Media by Atomic Force Microscopy. ACS sustainable chemistry & engineering, 2(7), 1681-1690. https://doi.org/10.1021/sc500152g
Pyrgiotakis, Georgios, et al. "Real-Time Nanoparticle-Cell Interactions in Physiological Media by Atomic Force Microscopy." ACS sustainable chemistry & engineering vol. 2,7 (2014): 1681-1690. doi: https://doi.org/10.1021/sc500152g
Pyrgiotakis G, Blattmann CO, Demokritou P. Real-Time Nanoparticle-Cell Interactions in Physiological Media by Atomic Force Microscopy. ACS Sustain Chem Eng. 2014 Jul 07;2(7):1681-1690. doi: 10.1021/sc500152g. Epub 2014 Jun 10. PMID: 25068097; PMCID: PMC4105194.
Copy Download .nbib Format: NLM
Vein Patch Closure Using Below the Knee Greater Saphenous Vein for Femoral Endarterectomy Procedures is Not Always a Safe Choice.

EJVES short reports

Berner M, Lattmann T, Stalder P, Wigger P.
PMID: 29234736
EJVES Short Rep. 2017 Nov 07;37:22-24. doi: 10.1016/j.ejvssr.2017.10.001. eCollection 2017.

BACKGROUND: The complication of vein patch rupture is well described after carotid patch angioplasty; however, there is a paucity of data about the safety of vein patch closure in the setting of femoral endarterectomy.METHODS/RESULTS: From May 2012 to May...

Cite
Berner M, Lattmann T, Stalder P, et al. Vein Patch Closure Using Below the Knee Greater Saphenous Vein for Femoral Endarterectomy Procedures is Not Always a Safe Choice. EJVES Short Rep. 2017;37:22-24doi: 10.1016/j.ejvssr.2017.10.001.
Berner, M., Lattmann, T., Stalder, P., & Wigger, P. (2017). Vein Patch Closure Using Below the Knee Greater Saphenous Vein for Femoral Endarterectomy Procedures is Not Always a Safe Choice. EJVES short reports, 3722-24. https://doi.org/10.1016/j.ejvssr.2017.10.001
Berner, M, et al. "Vein Patch Closure Using Below the Knee Greater Saphenous Vein for Femoral Endarterectomy Procedures is Not Always a Safe Choice." EJVES short reports vol. 37 (2017): 22-24. doi: https://doi.org/10.1016/j.ejvssr.2017.10.001
Berner M, Lattmann T, Stalder P, Wigger P. Vein Patch Closure Using Below the Knee Greater Saphenous Vein for Femoral Endarterectomy Procedures is Not Always a Safe Choice. EJVES Short Rep. 2017 Nov 07;37:22-24. doi: 10.1016/j.ejvssr.2017.10.001. eCollection 2017. PMID: 29234736; PMCID: PMC5721262.
Copy Download .nbib Format: NLM
Single-Step Fabrication of Polymer Nanocomposite Films.

Materials (Basel, Switzerland)

Blattmann CO, Pratsinis SE.
PMID: 29996508
Materials (Basel). 2018 Jul 10;11(7). doi: 10.3390/ma11071177.

Polymer nanocomposites are employed in (micro)electronic, biomedical, structural and optical applications. Their fabrication is challenging due to nanoparticle (filler) agglomeration and settling, increased viscosity of blended solutions and multiple tedious processing steps, just to name a few. Often this...

Cite
Blattmann CO, Pratsinis SE. Single-Step Fabrication of Polymer Nanocomposite Films. Materials (Basel). 2018;11(7)doi: 10.3390/ma11071177.
Blattmann, C. O., & Pratsinis, S. E. (2018). Single-Step Fabrication of Polymer Nanocomposite Films. Materials (Basel, Switzerland), 11(7), . https://doi.org/10.3390/ma11071177
Blattmann, Christoph O, and Pratsinis, Sotiris E. "Single-Step Fabrication of Polymer Nanocomposite Films." Materials (Basel, Switzerland) vol. 11,7 (2018). doi: https://doi.org/10.3390/ma11071177
Blattmann CO, Pratsinis SE. Single-Step Fabrication of Polymer Nanocomposite Films. Materials (Basel). 2018 Jul 10;11(7). doi: 10.3390/ma11071177. PMID: 29996508; PMCID: PMC6073108.
Copy Download .nbib Format: NLM
No Overt Clinical Immunodeficiency Despite Immune Biological Abnormalities in Patients With Constitutional Mismatch Repair Deficiency.

Frontiers in immunology

Tesch VK, IJspeert H, Raicht A, Rueda D, Dominguez-Pinilla N, Allende LM, Colas C, Rosenbaum T, Ilencikova D, Baris HN, Nathrath MHM, Suerink M, Januszkiewicz-Lewandowska D, Ragab I, Azizi AA, Wenzel SS, Zschocke J, Schwinger W, Kloor M, Blattmann C, Brugieres L, van der Burg M, Wimmer K, Seidel MG.
PMID: 30013564
Front Immunol. 2018 Jul 02;9:1506. doi: 10.3389/fimmu.2018.01506. eCollection 2018.

Immunoglobulin class-switch recombination (CSR) and somatic hypermutations (SHMs) are prerequisites for antibody and immunoglobulin receptor maturation and adaptive immune diversity. The mismatch repair (MMR) machinery, consisting of homologs of MutSα, MutLα, and MutSβ (MSH2/MSH6, MLH1/PMS2, and MSH2/MSH3, respectively) and...

Cite
Tesch VK, IJspeert H, Raicht A, et al. No Overt Clinical Immunodeficiency Despite Immune Biological Abnormalities in Patients With Constitutional Mismatch Repair Deficiency. Front Immunol. 2018;9:1506doi: 10.3389/fimmu.2018.01506.
Tesch, V. K., IJspeert, H., Raicht, A., Rueda, D., Dominguez-Pinilla, N., Allende, L. M., Colas, C., Rosenbaum, T., Ilencikova, D., Baris, H. N., Nathrath, M. H. M., Suerink, M., Januszkiewicz-Lewandowska, D., Ragab, I., Azizi, A. A., Wenzel, S. S., Zschocke, J., Schwinger, W., Kloor, M., Blattmann, C., Brugieres, L., van der Burg, M., Wimmer, K., & Seidel, M. G. (2018). No Overt Clinical Immunodeficiency Despite Immune Biological Abnormalities in Patients With Constitutional Mismatch Repair Deficiency. Frontiers in immunology, 91506. https://doi.org/10.3389/fimmu.2018.01506
Tesch, Victoria K, et al. "No Overt Clinical Immunodeficiency Despite Immune Biological Abnormalities in Patients With Constitutional Mismatch Repair Deficiency." Frontiers in immunology vol. 9 (2018): 1506. doi: https://doi.org/10.3389/fimmu.2018.01506
Tesch VK, IJspeert H, Raicht A, Rueda D, Dominguez-Pinilla N, Allende LM, Colas C, Rosenbaum T, Ilencikova D, Baris HN, Nathrath MHM, Suerink M, Januszkiewicz-Lewandowska D, Ragab I, Azizi AA, Wenzel SS, Zschocke J, Schwinger W, Kloor M, Blattmann C, Brugieres L, van der Burg M, Wimmer K, Seidel MG. No Overt Clinical Immunodeficiency Despite Immune Biological Abnormalities in Patients With Constitutional Mismatch Repair Deficiency. Front Immunol. 2018 Jul 02;9:1506. doi: 10.3389/fimmu.2018.01506. eCollection 2018. PMID: 30013564; PMCID: PMC6036136.
Copy Download .nbib Format: NLM
Author Correction: The landscape of genomic alterations across childhood cancers.

Nature

Gröbner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, Johann PD, Balasubramanian GP, Segura-Wang M, Brabetz S, Bender S, Hutter B, Sturm D, Pfaff E, Hübschmann D, Zipprich G, Heinold M, Eils J, Lawerenz C, Erkek S, Lambo S, Waszak S, Blattmann C, Borkhardt A, Kuhlen M, Eggert A, Fulda S, Gessler M, Wegert J, Kappler R, Baumhoer D, Burdach S, Kirschner-Schwabe R, Kontny U, Kulozik AE, Lohmann D, Hettmer S, Eckert C, Bielack S, Nathrath M, Niemeyer C, Richter GH, Schulte J, Siebert R, Westermann F, Molenaar JJ, Vassal G, Witt H, Burkhardt B, Kratz CP, Witt O, van Tilburg CM, Kramm CM, Fleischhack G, Dirksen U, Rutkowski S, Frühwald M, von Hoff K, Wolf S, Klingebiel T, Koscielniak E, Landgraf P, Koster J, Resnick AC, Zhang J, Liu Y, Zhou X, Waanders AJ, Zwijnenburg DA, Raman P, Brors B, Weber UD, Northcott PA, Pajtler KW, Kool M, Piro RM, Korbel JO, Schlesner M, Eils R, Jones DTW, Lichter P, Chavez L, Zapatka M, Pfister SM.
PMID: 29875405
Nature. 2018 Jul;559(7714):E10. doi: 10.1038/s41586-018-0167-2.

In this Article, author Benedikt Brors was erroneously associated with affiliation number '8' (Department of Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, Tennessee, USA); the author's two other affiliations (affiliations '3' and '7', both at the German Cancer...

Cite
Gröbner SN, Worst BC, Weischenfeldt J, et al. Author Correction: The landscape of genomic alterations across childhood cancers. Nature. 2018;559(7714):E10doi: 10.1038/s41586-018-0167-2.
Gröbner, S. N., Worst, B. C., Weischenfeldt, J., Buchhalter, I., Kleinheinz, K., Rudneva, V. A., Johann, P. D., Balasubramanian, G. P., Segura-Wang, M., Brabetz, S., Bender, S., Hutter, B., Sturm, D., Pfaff, E., Hübschmann, D., Zipprich, G., Heinold, M., Eils, J., Lawerenz, C., Erkek, S., Lambo, S., Waszak, S., Blattmann, C., Borkhardt, A., Kuhlen, M., Eggert, A., Fulda, S., Gessler, M., Wegert, J., Kappler, R., Baumhoer, D., Burdach, S., Kirschner-Schwabe, R., Kontny, U., Kulozik, A. E., Lohmann, D., Hettmer, S., Eckert, C., Bielack, S., Nathrath, M., Niemeyer, C., Richter, G. H., Schulte, J., Siebert, R., Westermann, F., Molenaar, J. J., Vassal, G., Witt, H., Burkhardt, B., Kratz, C. P., Witt, O., van Tilburg, C. M., Kramm, C. M., Fleischhack, G., Dirksen, U., Rutkowski, S., Frühwald, M., von Hoff, K., Wolf, S., Klingebiel, T., Koscielniak, E., Landgraf, P., Koster, J., Resnick, A. C., Zhang, J., Liu, Y., Zhou, X., Waanders, A. J., Zwijnenburg, D. A., Raman, P., Brors, B., Weber, U. D., Northcott, P. A., Pajtler, K. W., Kool, M., Piro, R. M., Korbel, J. O., Schlesner, M., Eils, R., Jones, D. T. W., Lichter, P., Chavez, L., Zapatka, M., Pfister, S. M. (2018). Author Correction: The landscape of genomic alterations across childhood cancers. Nature, 559(7714), E10. https://doi.org/10.1038/s41586-018-0167-2
Gröbner, Susanne N, et al. "Author Correction: The landscape of genomic alterations across childhood cancers." Nature vol. 559,7714 (2018): E10. doi: https://doi.org/10.1038/s41586-018-0167-2
Gröbner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, Johann PD, Balasubramanian GP, Segura-Wang M, Brabetz S, Bender S, Hutter B, Sturm D, Pfaff E, Hübschmann D, Zipprich G, Heinold M, Eils J, Lawerenz C, Erkek S, Lambo S, Waszak S, Blattmann C, Borkhardt A, Kuhlen M, Eggert A, Fulda S, Gessler M, Wegert J, Kappler R, Baumhoer D, Burdach S, Kirschner-Schwabe R, Kontny U, Kulozik AE, Lohmann D, Hettmer S, Eckert C, Bielack S, Nathrath M, Niemeyer C, Richter GH, Schulte J, Siebert R, Westermann F, Molenaar JJ, Vassal G, Witt H, Burkhardt B, Kratz CP, Witt O, van Tilburg CM, Kramm CM, Fleischhack G, Dirksen U, Rutkowski S, Frühwald M, von Hoff K, Wolf S, Klingebiel T, Koscielniak E, Landgraf P, Koster J, Resnick AC, Zhang J, Liu Y, Zhou X, Waanders AJ, Zwijnenburg DA, Raman P, Brors B, Weber UD, Northcott PA, Pajtler KW, Kool M, Piro RM, Korbel JO, Schlesner M, Eils R, Jones DTW, Lichter P, Chavez L, Zapatka M, Pfister SM. Author Correction: The landscape of genomic alterations across childhood cancers. Nature. 2018 Jul;559(7714):E10. doi: 10.1038/s41586-018-0167-2. PMID: 29875405.
Copy Download .nbib Format: NLM
Left ventricular unloading during extracorporeal life support for myocardial infarction with cardiogenic shock: surgical venting versus Impella device.

Interactive cardiovascular and thoracic surgery

Radakovic D, Zittermann A, Knezevic A, Razumov A, Opacic D, Wienrautner N, Flottmann C, Rojas SV, Fox H, Schramm R, Morshuis M, Rudolph V, Gummert J, Deutsch MA.
PMID: 34392345
Interact Cardiovasc Thorac Surg. 2021 Aug 15; doi: 10.1093/icvts/ivab230. Epub 2021 Aug 15.

OBJECTIVES: Patients in cardiogenic shock supported with venoarterial extracorporeal membrane oxygenation (VA-ECMO) may experience severe complications from reduced left ventricular (LV) unloading and increased cardiac afterload. These effects are usually modified by adding a percutaneous direct Impella vent or...

Cite
Radakovic D, Zittermann A, Knezevic A, et al. Left ventricular unloading during extracorporeal life support for myocardial infarction with cardiogenic shock: surgical venting versus Impella device. Interact Cardiovasc Thorac Surg. 2021;doi: 10.1093/icvts/ivab230.
Radakovic, D., Zittermann, A., Knezevic, A., Razumov, A., Opacic, D., Wienrautner, N., Flottmann, C., Rojas, S. V., Fox, H., Schramm, R., Morshuis, M., Rudolph, V., Gummert, J., & Deutsch, M. A. (2021). Left ventricular unloading during extracorporeal life support for myocardial infarction with cardiogenic shock: surgical venting versus Impella device. Interactive cardiovascular and thoracic surgery, . https://doi.org/10.1093/icvts/ivab230
Radakovic, Darko, et al. "Left ventricular unloading during extracorporeal life support for myocardial infarction with cardiogenic shock: surgical venting versus Impella device." Interactive cardiovascular and thoracic surgery vol. (2021). doi: https://doi.org/10.1093/icvts/ivab230
Radakovic D, Zittermann A, Knezevic A, Razumov A, Opacic D, Wienrautner N, Flottmann C, Rojas SV, Fox H, Schramm R, Morshuis M, Rudolph V, Gummert J, Deutsch MA. Left ventricular unloading during extracorporeal life support for myocardial infarction with cardiogenic shock: surgical venting versus Impella device. Interact Cardiovasc Thorac Surg. 2021 Aug 15; doi: 10.1093/icvts/ivab230. Epub 2021 Aug 15. PMID: 34392345.
Copy Download .nbib Format: NLM
[Treatment reality of aortic diseases in Switzerland].

Gefasschirurgie : Zeitschrift fur vaskulare und endovaskulare Chirurgie : Organ der Deutschen und der Osterreichischen Gesellschaft fur Gefasschirurgie unter Mitarbeit der Schweizerischen Gesellschaft fur Gefasschirurgie

Meuli L, Lattmann T.
PMID: 34092930
Gefasschirurgie. 2021 Jun 01;1-9. doi: 10.1007/s00772-021-00782-0. Epub 2021 Jun 01.

BACKGROUND: Due to the federally organized healthcare system in Switzerland, aortic interventions are performed in many different hospitals, presumably sometimes with a very small number of cases per institution. The aim of this study was to present the treatment...

Cite
Meuli L, Lattmann T. Versorgungsrealität von Aortenerkrankungen in der Schweiz. [Treatment reality of aortic diseases in Switzerland]. Gefasschirurgie. 2021;1-9doi: 10.1007/s00772-021-00782-0.
Meuli, L., & Lattmann, T. (2021). Versorgungsrealität von Aortenerkrankungen in der Schweiz. [Treatment reality of aortic diseases in Switzerland]. Gefasschirurgie : Zeitschrift fur vaskulare und endovaskulare Chirurgie : Organ der Deutschen und der Osterreichischen Gesellschaft fur Gefasschirurgie unter Mitarbeit der Schweizerischen Gesellschaft fur Gefasschirurgie, 1-9. https://doi.org/10.1007/s00772-021-00782-0
Meuli, L, and Lattmann, T. "Versorgungsrealität von Aortenerkrankungen in der Schweiz." [Treatment reality of aortic diseases in Switzerland]. Gefasschirurgie : Zeitschrift fur vaskulare und endovaskulare Chirurgie : Organ der Deutschen und der Osterreichischen Gesellschaft fur Gefasschirurgie unter Mitarbeit der Schweizerischen Gesellschaft fur Gefasschirurgie vol. (2021): 1-9. doi: https://doi.org/10.1007/s00772-021-00782-0
Meuli L, Lattmann T. Versorgungsrealität von Aortenerkrankungen in der Schweiz. [Treatment reality of aortic diseases in Switzerland]. Gefasschirurgie. 2021 Jun 01;1-9. doi: 10.1007/s00772-021-00782-0. Epub 2021 Jun 01. German. PMID: 34092930; PMCID: PMC8168293.
Copy Download .nbib Format: NLM
Temperature influences growth and maturation of fruit on 'Hayward' kiwifruit vines.

Functional plant biology : FPB

Snelgar WP, Hall AJ, Ferguson AR, Blattmann P.
PMID: 32689162
Funct Plant Biol. 2005 Aug;32(7):631-642. doi: 10.1071/FP05062.

The responses of fruit and shoot growth of 'Hayward' kiwifruit vines to changes of temperature were determined during spring, summer or autumn. Mature vines were warmed 2-5°C above ambient temperatures by enclosing them in temperature-controlled tunnel houses for 34-89...

Cite
Snelgar WP, Hall AJ, Ferguson AR, et al. Temperature influences growth and maturation of fruit on 'Hayward' kiwifruit vines. Funct Plant Biol. 2005;32(7):631-642doi: 10.1071/FP05062.
Snelgar, W. P., Hall, A. J., Ferguson, A. R., & Blattmann, P. (2005). Temperature influences growth and maturation of fruit on 'Hayward' kiwifruit vines. Functional plant biology : FPB, 32(7), 631-642. https://doi.org/10.1071/FP05062
Snelgar, William P, et al. "Temperature influences growth and maturation of fruit on 'Hayward' kiwifruit vines." Functional plant biology : FPB vol. 32,7 (2005): 631-642. doi: https://doi.org/10.1071/FP05062
Snelgar WP, Hall AJ, Ferguson AR, Blattmann P. Temperature influences growth and maturation of fruit on 'Hayward' kiwifruit vines. Funct Plant Biol. 2005 Aug;32(7):631-642. doi: 10.1071/FP05062. PMID: 32689162.
Copy Download .nbib Format: NLM
Cholecystokinin-2/gastrin antagonists: 5-hydroxy-5-aryl-pyrrol-2-ones as anti-inflammatory analgesics for the treatment of inflammatory bowel disease.

MedChemComm

Lattmann E, Sattayasai J, Narayanan R, Ngoc N, Burrell D, Balaram PN, Palizdar T, Lattmann P.
PMID: 30108786
Medchemcomm. 2017 Feb 17;8(3):680-685. doi: 10.1039/c6md00707d. eCollection 2017 Mar 01.

Arylated 5-hydroxy-pyrrol-2-ones were prepared in 2 synthetic steps from mucochloric acid and optimised as CCK

Cite
Lattmann E, Sattayasai J, Narayanan R, et al. Cholecystokinin-2/gastrin antagonists: 5-hydroxy-5-aryl-pyrrol-2-ones as anti-inflammatory analgesics for the treatment of inflammatory bowel disease. Medchemcomm. 2017;8(3):680-685doi: 10.1039/c6md00707d.
Lattmann, E., Sattayasai, J., Narayanan, R., Ngoc, N., Burrell, D., Balaram, P. N., Palizdar, T., & Lattmann, P. (2017). Cholecystokinin-2/gastrin antagonists: 5-hydroxy-5-aryl-pyrrol-2-ones as anti-inflammatory analgesics for the treatment of inflammatory bowel disease. MedChemComm, 8(3), 680-685. https://doi.org/10.1039/c6md00707d
Lattmann, E, et al. "Cholecystokinin-2/gastrin antagonists: 5-hydroxy-5-aryl-pyrrol-2-ones as anti-inflammatory analgesics for the treatment of inflammatory bowel disease." MedChemComm vol. 8,3 (2017): 680-685. doi: https://doi.org/10.1039/c6md00707d
Lattmann E, Sattayasai J, Narayanan R, Ngoc N, Burrell D, Balaram PN, Palizdar T, Lattmann P. Cholecystokinin-2/gastrin antagonists: 5-hydroxy-5-aryl-pyrrol-2-ones as anti-inflammatory analgesics for the treatment of inflammatory bowel disease. Medchemcomm. 2017 Feb 17;8(3):680-685. doi: 10.1039/c6md00707d. eCollection 2017 Mar 01. PMID: 30108786; PMCID: PMC6072330.
Copy Download .nbib Format: NLM
In Situ Monitoring of the Deposition of Flame-Made Chemoresistive Gas-Sensing Films.

ACS applied materials & interfaces

Blattmann CO, Güntner AT, Pratsinis SE.
PMID: 28621930
ACS Appl Mater Interfaces. 2017 Jul 19;9(28):23926-23933. doi: 10.1021/acsami.7b04530. Epub 2017 Jul 06.

Flame-deposited semiconducting nanomaterials on microelectronic circuitry exhibit exceptional performance as chemoresistive gas sensors. Current manufacturing technology, however, does not monitor in situ the formation of such nanostructured films, even though this can facilitate the controlled and economic synthesis of...

Cite
Blattmann CO, Güntner AT, Pratsinis SE. In Situ Monitoring of the Deposition of Flame-Made Chemoresistive Gas-Sensing Films. ACS Appl Mater Interfaces. 2017;9(28):23926-23933doi: 10.1021/acsami.7b04530.
Blattmann, C. O., Güntner, A. T., & Pratsinis, S. E. (2017). In Situ Monitoring of the Deposition of Flame-Made Chemoresistive Gas-Sensing Films. ACS applied materials & interfaces, 9(28), 23926-23933. https://doi.org/10.1021/acsami.7b04530
Blattmann, Christoph O, et al. "In Situ Monitoring of the Deposition of Flame-Made Chemoresistive Gas-Sensing Films." ACS applied materials & interfaces vol. 9,28 (2017): 23926-23933. doi: https://doi.org/10.1021/acsami.7b04530
Blattmann CO, Güntner AT, Pratsinis SE. In Situ Monitoring of the Deposition of Flame-Made Chemoresistive Gas-Sensing Films. ACS Appl Mater Interfaces. 2017 Jul 19;9(28):23926-23933. doi: 10.1021/acsami.7b04530. Epub 2017 Jul 06. PMID: 28621930.
Copy Download .nbib Format: NLM
Nuclear factor kappa B is required for the production of infectious human herpesvirus 8 virions.

Frontiers in microbiology

Blattman NN, Lagunoff M, Blattman JN, Corey L.
PMID: 24795700
Front Microbiol. 2014 Apr 04;5:129. doi: 10.3389/fmicb.2014.00129. eCollection 2014.

Human herpesvirus 8 (HHV8) infection leads to potent activation of nuclear factor kappa B (NFκB) in primary and transformed cells. We used recombinant HHV8 (rKSHV.219) expressing green fluorescent protein under the constitutive cellular promoter elongation factor 2α and red...

Cite
Blattman NN, Lagunoff M, Blattman JN, et al. Nuclear factor kappa B is required for the production of infectious human herpesvirus 8 virions. Front Microbiol. 2014;5:129doi: 10.3389/fmicb.2014.00129.
Blattman, N. N., Lagunoff, M., Blattman, J. N., & Corey, L. (2014). Nuclear factor kappa B is required for the production of infectious human herpesvirus 8 virions. Frontiers in microbiology, 5129. https://doi.org/10.3389/fmicb.2014.00129
Blattman, Negin N, et al. "Nuclear factor kappa B is required for the production of infectious human herpesvirus 8 virions." Frontiers in microbiology vol. 5 (2014): 129. doi: https://doi.org/10.3389/fmicb.2014.00129
Blattman NN, Lagunoff M, Blattman JN, Corey L. Nuclear factor kappa B is required for the production of infectious human herpesvirus 8 virions. Front Microbiol. 2014 Apr 04;5:129. doi: 10.3389/fmicb.2014.00129. eCollection 2014. PMID: 24795700; PMCID: PMC4006053.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 53 entries